Atlas Trials

Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis

Clinical trial NCT02380131 · UNKNOWN

Trial details

NCT number
NCT02380131
Sponsor
Hebei Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HER-2 Positive Gastric CancerLiver Metastasis
Start date
2013-02-01
Primary completion
2017-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.